Related Experiment Video
Updated: May 31, 2026

07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Expandable metal stents for benign biliary disease
Mihir R Bakhru1, Michel Kahaleh
1Division of Gastroenterology and Hepatology, University of Virginia, PO Box 800708, Charlottesville, VA 22908, USA.
Gastrointestinal Endoscopy Clinics of North America
|June 21, 2011
Summary
Self-expanding metal stents (SEMS) offer endoscopic treatment for benign biliary diseases like strictures and leaks. While effective, complications associated with SEMS use require careful consideration for their role in treatment.
Area of Science:
- Gastroenterology and Hepatology
- Interventional Endoscopy
- Biliary Tract Diseases
Background:
- Benign biliary diseases (BBD) encompass benign biliary strictures (BBS), choledocholithiasis, and leaks.
- BBS etiologies include postoperative injury, anastomotic strictures, chronic pancreatitis, primary sclerosing cholangitis, and gallstone disease.
- Treatment modalities for BBD involve surgical, percutaneous, and endoscopic interventions.
Purpose of the Study:
- To review the published experience with self-expanding metal stents (SEMS) in treating benign biliary diseases.
- To define the current role and limitations of SEMS in the management of benign biliary strictures and leaks.
Main Methods:
- Review of published literature on the use of SEMS for benign biliary diseases.
- Analysis of outcomes and complications associated with different types of SEMS (uncovered, partially covered, fully covered).
Main Results:
- SEMS have demonstrated success in resolving benign biliary strictures and leaks.
- Complications associated with SEMS implantation can limit their therapeutic application.
- Different SEMS configurations show varying degrees of efficacy and safety.
Conclusions:
- SEMS represent a viable endoscopic option for managing certain benign biliary diseases.
- Further research is needed to optimize SEMS use and mitigate associated complications.
- The role of SEMS in benign biliary disease treatment is evolving, balancing efficacy with safety concerns.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...